Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs

被引:9
作者
Amendah, Djesika D. [1 ]
Mukamah, George [2 ]
Komba, Albert [2 ]
Ndila, Carolyne [2 ]
Williams, Thomas N. [2 ,3 ,4 ,5 ]
机构
[1] African Populat Hlth Res Ctr, Nairobi, Kenya
[2] Ctr Geog Med Res Coast, Kenya Med Res Inst KEMRI, Kilifi, Kenya
[3] INDEPTH Network Demog Surveillance Sites, Accra, Ghana
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
[5] Global Network Sickle Cell Dis, Toronto, ON, Canada
来源
PLOS ONE | 2013年 / 8卷 / 04期
基金
英国惠康基金;
关键词
HEALTH-CARE; CHILDREN; EXPENDITURES; PROGRAM; COHORT; ADULTS;
D O I
10.1371/journal.pone.0061130
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: More than 70% of children with sickle cell disease (SCD) are born in sub-Saharan Africa where the prevalence at birth of this disease reaches 2% or higher in some selected areas. There is a dearth of knowledge on comprehensive care received by children with SCD in sub-Saharan Africa and its associated cost. Such knowledge is important for setting prevention and treatment priorities at national and international levels. This study focuses on routine care for children with SCD in an outpatient clinic of the Kilifi District Hospital, located in a rural area on the coast of Kenya. Objective: To estimate the per-patient costs for routine SCD outpatient care at a rural Kenyan hospital. Methods: We collected routine administrative and primary cost data from the SCD outpatient clinic and supporting departments at Kilifi District Hospital, Kenya. Costs were estimated by evaluating inputs - equipment, medication, supplies, building use, utility, and personnel - to reflect the cost of offering this service within an existing healthcare facility. Annual economic costs were similarly calculated based on input costs, prorated lifetime of equipment and appropriate discount rate. Sensitivity analyses evaluated these costs under different pay scales and different discount rate. Results: We estimated that the annual economic cost per patient attending the SCD clinic was USD 138 in 2010 with a range of USD 94 to USD 229. Conclusion: This study supplies the first published estimate of the cost of routine outpatient care for children born with SCD in sub-Saharan Africa. Our study provides policy makers with an indication of the potential future costs of maintaining specialist outpatient clinics for children living with SCD in similar contexts.
引用
收藏
页数:6
相关论文
共 45 条
  • [31] Gaps during pediatric to adult care transfer escalate acute resource utilization in sickle cell disease
    Howell, Kristen E.
    Kayle, Mariam
    Smeltzer, Matthew P.
    Nolan, Vikki G.
    Mathias, Joacy G.
    Nelson, Marquita
    Anderson, Sheila
    Porter, Jerlym S.
    Shah, Nirmish
    Hankins, Jane S.
    [J]. BLOOD ADVANCES, 2024, 8 (14) : 3679 - 3685
  • [32] Emergency Department Utilization for Patients Living With Sickle Cell Disease: Psychosocial Predictors of Health Care Behaviors
    Abdallah, Khadijah
    Buscetta, Ashley
    Cooper, Kayla
    Byeon, Julia
    Crouch, Andrew
    Pink, Sabrina
    Minniti, Caterina
    Bonham, Vence L.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2020, 76 (03) : S56 - S63
  • [33] Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia
    Vekeman, Francis
    Sasane, Medha
    Cheng, Wendy Y.
    Ramanakumar, Agnihotram V.
    Fortier, Jonathan
    Qiu, Ying
    Duh, Mei Sheng
    Paley, Carole
    Adams-Graves, Patricia
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) : 292 - 303
  • [34] Unmet legal and social advocacy needs of children with sickle cell disease: Implications for health care payer costs
    Sonik, Rajan A.
    Teasdale, Sarah
    Parish, Susan L.
    Champigny, Maria
    Sprinz, Philippa G.
    [J]. CHILDREN AND YOUTH SERVICES REVIEW, 2018, 84 : 76 - 81
  • [35] Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study
    Hankins, Jane S.
    Shah, Nirmish
    DiMartino, Lisa
    Brambilla, Donald
    Fernandez, Maria E.
    Gibson, Robert W.
    Gordeuk, Ictor R.
    Lottenberg, Richard
    Kutlar, Abdullah
    Melvin, Cathy
    Simon, Jena
    Wun, Ted
    Treadwell, Marsha
    Calhoun, Cecelia
    Baumann, Ana
    Potter, Michael B.
    Klesges, Lisa
    Bosworth, Hayden
    [J]. JMIR RESEARCH PROTOCOLS, 2020, 9 (07):
  • [36] Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital
    Binding, Andrew
    [J]. HEMOGLOBIN, 2022, 46 (02) : 91 - 94
  • [37] Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals
    Raphael, Jean L.
    Richardson, Troy
    Hall, Matt
    Oyeku, Suzette O.
    Bundy, David G.
    Kalpatthi, Ram V.
    Shah, Samir S.
    Ellison, Angela M.
    [J]. JOURNAL OF PEDIATRICS, 2015, 167 (06) : 1306 - 1313
  • [38] Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country
    Lobo, Clarisse
    Moura, Patricia
    Fidlarczyk, Delaine
    Duran, Jane
    Barbosa, Roberto
    Oliveira, Thais
    do Nascimento, Emilia Matos
    Bhakta, Nickhill
    Hankins, Jane S.
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [39] Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
    Gupta, Gajendra Kumar
    Sarkar, Purnima Dey
    Manyal, Rohit
    Rajput, Mithun Singh
    [J]. BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2022, 6 (01): : 81 - 85
  • [40] Preliminary exploration of secondhand smoke exposure in youth with Sickle Cell Disease: biochemical verification, pulmonary functioning, and health care utilization
    Tackett, Alayna P.
    Leavens, Eleanor L. S.
    Wiedenmann, Alex
    Perez, Megan N.
    Baker, Ashley
    Mayes, Sunnye
    Mullins, Larry L.
    Wagener, Theodore L.
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2019, 24 (01) : 35 - 42